News from dynacure A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Oct 02, 2019, 10:45 ET Dynacure Presents New Preclinical Results on Muscle Targeting with Antisense Oligonucleotides at the 24th Annual International Congress of the World Muscle Society

Dynacure, a clinical stage drug development company focused on improving the lives of patients with rare and orphan disorders, today announced two...


Sep 11, 2019, 08:00 ET Dynacure to Present at Chardan's 3rd Annual Genetic Medicines Conference

Dynacure, a clinical stage drug development company focused on improving the lives of patients with rare and orphan disorders, today announced that...


Sep 03, 2019, 08:00 ET Dynacure Appoints David Garrett as Chief Financial Officer

Dynacure, a clinical stage drug development company focused on improving the lives of patients with rare and orphan disorders, today announced the...


Aug 08, 2019, 11:21 ET Dynacure Receives Orphan Drug Designation from the US FDA for DYN101, an Antisense Medicine to Treat Rare Disease 'Centronuclear Myopathies'

Dynacure, a clinical stage drug development company focused on improving the lives of patients with rare and orphan disorders, today announced that...


Apr 30, 2019, 03:00 ET Dynacure Announces Approval of Clinical Trial Application for DYN101, an Antisense Medicine to Treat Rare Disease 'Centronuclear Myopathies'

Dynacure, a clinical stage drug development company focused on improving the lives of patients with rare and orphan disorders, today announced that...